ストックスクリーナーアプリを入手
13.17
3.05%
0.39
前日終値:
$12.78
開ける：
$13
24時間の取引高:
200.88K
Relative Volume:
0.83
時価総額：
$666.44M
収益：
-
当期純損益:
$-83.74M
株価収益率:
-8.1801
EPS:
-1.61
ネットキャッシュフロー:
$-64.98M
1週間 パフォーマンス:
-0.15%
1か月 パフォーマンス:
-17.22%
6か月 パフォーマンス:
-41.93%
1年 パフォーマンス:
-31.51%
1日の値動き範囲:
$12.88
$13.46
1週間の範囲:
$12.27
$13.79
52週間の値動き範囲:
$11.88
$29.60
Tyra Biosciences Inc Stock (TYRA) Company Profile
TYRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TYRA
Tyra Biosciences Inc
|
13.17 | 666.44M | 0 | -83.74M | -64.98M | -1.61 |
|
VRTX
Vertex Pharmaceuticals Inc
|
484.24 | 124.35B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
700.33 | 76.56B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
644.48 | 39.16B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
250.59 | 32.44B | 2.25B | -278.16M | -42.59M | -2.17 |
|
BNTX
Biontech Se Adr
|
120.01 | 28.77B | 3.30B | -501.07M | 1.03B | -2.1146 |
Tyra Biosciences Inc Stock (TYRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-07 | 開始されました | UBS | Buy |
| 2024-10-18 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-08-15 | 開始されました | Piper Sandler | Overweight |
| 2023-12-15 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-06-30 | 開始されました | Wedbush | Outperform |
| 2023-02-03 | 開始されました | Oppenheimer | Outperform |
| 2022-06-23 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-08 | アップグレード | Jefferies | Hold → Buy |
| 2021-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2021-10-11 | 開始されました | BofA Securities | Buy |
| 2021-10-11 | 開始されました | Cowen | Outperform |
| 2021-10-11 | 開始されました | Jefferies | Buy |
すべてを表示
Tyra Biosciences Inc (TYRA) 最新ニュース
(TYRA) Investment Analysis - Stock Traders Daily
Tyra Biosciences Inc (TYRA) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings - ACCESS Newswire
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Investors to Contact the Firm Today! - ACCESS Newswire
Tyra Biosciences' (TYRA) Buy Rating Reiterated at HC Wainwright - MarketBeat
Tyra Biosciences (NASDAQ:TYRA) Given “Buy” Rating at HC Wainwright - Defense World
Tyra Biosciences (NASDAQ:TYRA) Stock Price Up 6.6%Here's What Happened - MarketBeat
Tyra Biosciences director Nina Kjellson sells $78,466 in stock - MSN
Tyra Biosciences director Nina Kjellson sells $74,323 in stock - MSN
Tyra Biosciences (NASDAQ:TYRA) Reaches New 52-Week LowShould You Sell? - MarketBeat
Nina S. Kjellson Sells 5,401 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock - MarketBeat
Exclusive: Tyra Biosciences Sets Ambitious 4-Conference Roadshow Including Prestigious Biotech on the Beach - StockTitan
Tyra Biosciences (NASDAQ:TYRA) Sets New 1-Year LowHere's What Happened - MarketBeat
An Analysis of Tyra Biosciences Inc (TYRA)’s Potential Price Growth - Knox Daily
Financial Fitness Check: Examining Tyra Biosciences Inc (TYRA)’s Key Ratios - The Dwinnex
How to Take Advantage of moves in (TYRA) - Stock Traders Daily
Tyra Biosciences (NASDAQ:TYRA) Reaches New 12-Month Low – Here’s What Happened - Armenian Reporter
Tyra Biosciences director Nina Kjellson sells $74,323 in stock By Investing.com - Investing.com Australia
TYRA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Tyra Biosciences Inc and Encourages Shareholders to Contact the Firm! - ACCESS Newswire
Director’s Stock Sale Unveils Major Moves at Tyra Bioscience! - TipRanks
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Average Price Target from Analysts - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Receives $30.50 Consensus PT from Analysts - Defense World
Tyra Biosciences adds Adele Gulfo to board - MSN
Tyra Biosciences appoints new board member - MSN
Tyra Biosciences appoints new board member By Investing.com - Investing.com Australia
Tyra Biosciences Insider Ups Holding By 284% During Year - Simply Wall St
TYRA INVESTIGATION NOTICE: Kaskela Law LLC Announces Investigation of Tyra Biosciences, Inc. (TYRA) and Encourages Investors to Contact the Firm - ACCESS Newswire
Tyra Biosciences adds Adele Gulfo to board By Investing.com - Investing.com South Africa
Tyra Biosciences Announces Appointment of Adele Gulfo to Board of Directors - PR Newswire
(TYRA) Trading Advice - Stock Traders Daily
Tyra Biosciences director Nina Kjellson sells $78,466 in stock By Investing.com - Investing.com Australia
Insider Selling: Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells 4,825 Shares of Stock - MarketBeat
Private equity firms account for 44% of Tyra Biosciences, Inc.'s (NASDAQ:TYRA) ownership, while institutions account for 33% - Yahoo Finance
Tyra Biosciences, Inc. (NASDAQ:TYRA) is Canaan Partners XI LLC's Largest Position - MarketBeat
Tyra Biosciences, Inc. (NASDAQ:TYRA) Director Sells $126,719.91 in Stock - MarketBeat
Nina S. Kjellson Sells 3,993 Shares of Tyra Biosciences, Inc. (NASDAQ:TYRA) Stock - MarketBeat
Tyra Biosciences Announces Poster Presentations at 2025 ASCO Gastrointestinal Cancers Symposium - Citizentribune
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 By Investing.com - Investing.com Australia
Tyra Biosciences director Nina Kjellson sells shares worth $409,645 - MSN
Tyra Biosciences Inc (TYRA) 財務データ
収益
当期純利益
現金流量
EPS
0.27%
3.05%
大文字化:
|
ボリューム (24 時間):